Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256515 · ClinicalTrials.gov registry record · NA
Health Management Training to Enhance Influenza Vaccine Immunogenicity
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01256515: Completed NA study, sponsored by Massachusetts General Hospital.
NCT01256515 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01256515, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this study is to assess the immunogenicity of inactivated influenza vaccination (IIV) in healthy elderly volunteers aged 50 years and older receiving one of two different health management trainings.
Interventions
- BEHAVIORAL Health Education
- BEHAVIORAL Health Education Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-11 |
| Est. Completion | 2012-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01256515
The ClinicalTrials.gov registry entry for NCT01256515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Health Education is the first listed.
NCT01256515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01256515 about?
NCT01256515 is a clinical study titled "Health Management Training to Enhance Influenza Vaccine Immunogenicity". The goal of this study is to assess the immunogenicity of inactivated influenza vaccination (IIV) in healthy elderly volunteers aged 50 years and older receiving one of two different health management trainings.
What is the current status of trial NCT01256515?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2009-11. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01256515?
The interventions under investigation include: Health Education (BEHAVIORAL), Health Education Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01256515?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.